These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16220305)
1. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Annovazzi A; Bonanno E; Arca M; D'Alessandria C; Marcoccia A; Spagnoli LG; Violi F; Scopinaro F; De Toma G; Signore A Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):117-26. PubMed ID: 16220305 [TBL] [Abstract][Full Text] [Related]
2. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559 [TBL] [Abstract][Full Text] [Related]
3. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study. Signore A; Annovazzi A; Barone R; Bonanno E; D'Alessandria C; Chianelli M; Mather SJ; Bottoni U; Panetta C; Innocenzi D; Scopinaro F; Calvieri S J Nucl Med; 2004 Oct; 45(10):1647-52. PubMed ID: 15471828 [TBL] [Abstract][Full Text] [Related]
4. Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients. Opalinska M; Stompor T; Pach D; Mikolajczak R; Fedak D; Krzanowski M; Rakowski T; Sowa-Staszczak A; Glowa B; Garnuszek P; Maurin M; Karczmarczyk U; Sulowicz W; Hubalewska-Dydejczyk A Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):673-82. PubMed ID: 22237843 [TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound. Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015 [TBL] [Abstract][Full Text] [Related]
6. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice. Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030 [TBL] [Abstract][Full Text] [Related]
7. 123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease. Signore A; Chianelli M; Annovazzi A; Bonanno E; Spagnoli LG; Pozzilli P; Pallone F; Biancone L J Nucl Med; 2000 Feb; 41(2):242-9. PubMed ID: 10688106 [TBL] [Abstract][Full Text] [Related]
8. In vivo carotid plaque MRI using quantitative T2* measurements with ultrasmall superparamagnetic iron oxide particles: a dose-response study to statin therapy. Patterson AJ; Tang TY; Graves MJ; Müller KH; Gillard JH NMR Biomed; 2011 Jan; 24(1):89-95. PubMed ID: 21259368 [TBL] [Abstract][Full Text] [Related]
9. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. Tang TY; Howarth SP; Miller SR; Graves MJ; Patterson AJ; U-King-Im JM; Li ZY; Walsh SR; Brown AP; Kirkpatrick PJ; Warburton EA; Hayes PD; Varty K; Boyle JR; Gaunt ME; Zalewski A; Gillard JH J Am Coll Cardiol; 2009 Jun; 53(22):2039-50. PubMed ID: 19477353 [TBL] [Abstract][Full Text] [Related]
10. Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients. Yamagami H; Sakaguchi M; Furukado S; Hoshi T; Abe Y; Hougaku H; Hori M; Kitagawa K Ultrasound Med Biol; 2008 Sep; 34(9):1353-9. PubMed ID: 18378381 [TBL] [Abstract][Full Text] [Related]
11. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Martín-Ventura JL; Blanco-Colio LM; Gómez-Hernández A; Muñoz-García B; Vega M; Serrano J; Ortega L; Hernández G; Tuñón J; Egido J Stroke; 2005 Aug; 36(8):1796-800. PubMed ID: 16020773 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Durán MC; Martín-Ventura JL; Mohammed S; Barderas MG; Blanco-Colio LM; Mas S; Moral V; Ortega L; Tuñón J; Jensen ON; Vivanco F; Egido J Eur J Pharmacol; 2007 May; 562(1-2):119-29. PubMed ID: 17336287 [TBL] [Abstract][Full Text] [Related]
13. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104 [TBL] [Abstract][Full Text] [Related]
14. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin. Muñoz-García B; Martín-Ventura JL; Martínez E; Sánchez S; Hernández G; Ortega L; Ortiz A; Egido J; Blanco-Colio LM Stroke; 2006 Aug; 37(8):2044-53. PubMed ID: 16809572 [TBL] [Abstract][Full Text] [Related]
15. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Puato M; Faggin E; Rattazzi M; Zambon A; Cipollone F; Grego F; Ganassin L; Plebani M; Mezzetti A; Pauletto P Stroke; 2010 Jun; 41(6):1163-8. PubMed ID: 20413736 [TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Glaudemans AW; Bonanno E; Galli F; Zeebregts CJ; de Vries EF; Koole M; Luurtsema G; Boersma HH; Taurino M; Slart RH; Signore A Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1710-9. PubMed ID: 24737117 [TBL] [Abstract][Full Text] [Related]
17. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Annovazzi A; Biancone L; Caviglia R; Chianelli M; Capriotti G; Mather SJ; Caprilli R; Pallone F; Scopinaro F; Signore A Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):374-82. PubMed ID: 12634965 [TBL] [Abstract][Full Text] [Related]
18. 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice. Broisat A; Toczek J; Dumas LS; Ahmadi M; Bacot S; Perret P; Slimani L; Barone-Rochette G; Soubies A; Devoogdt N; Lahoutte T; Fagret D; Riou LM; Ghezzi C J Nucl Med; 2014 Oct; 55(10):1678-84. PubMed ID: 25157043 [TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. Kim DE; Kim JY; Schellingerhout D; Shon SM; Jeong SW; Kim EJ; Kim WK Mol Imaging; 2009; 8(5):291-301. PubMed ID: 19796606 [TBL] [Abstract][Full Text] [Related]
20. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]